JGP Global Gestao de Recursos’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,618
Closed -$226K 62
2020
Q4
$226K Buy
+2,618
New +$193K 0.85% 41
2020
Q1
Sell
-3,645
Closed -$263K 67
2019
Q4
$263K Buy
3,645
+44
+1% +$5.41K 0.09% 57
2019
Q3
$505K Buy
3,601
+71
+2% +$11.9K 0.28% 34
2019
Q2
$646K Sell
3,530
-1,957
-36% -$334K 0.25% 22
2019
Q1
$873K Buy
5,487
+504
+10% +$73K 0.32% 19
2018
Q4
$477K Buy
+4,983
New +$570K 0.58% 20

Other funds holding SAGE

JGP Global Gestao de Recursos's SAGE Position: Q1 2021 in Review

JGP Global Gestao de Recursos sold out of Sage Therapeutics (SAGE) in Q1 2021, closing a stake of 2,618 shares — an estimated $226K sold.

JGP Global Gestao de Recursos first reported a position in SAGE in Q4 2018 and held it in 6 quarters. The position peaked at $873K in Q1 2019. 262 funds tracked by Wall St. Rank hold SAGE as of Q1 2021.

  • JGP Global Gestao de Recursos reported no remaining Sage Therapeutics position as of Q1 2021 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 2,618 Sage Therapeutics shares in Q1 2021, an estimated $226K.
  • JGP Global Gestao de Recursos first reported a position in Sage Therapeutics in Q4 2018 and held it in 6 quarters.
  • JGP Global Gestao de Recursos's Sage Therapeutics position peaked at $873K in Q1 2019.
  • 262 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2021.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2021, filed 11 May 2021.